Elutia News and Activities

Elutia is a company listed under the stock ticker AZYO (US).

View the org chart displaying its 19 main executives

Most searched biographies at Elutia

• Randall Mills, President and Chief Executive Officer
• David Colpman, Director
• Brigid Makes, Director

Popular executive movements at Elutia

• Pete Ligotti has joined the company as Chief Commercial Officer  (posted on March 3 2026).
• Matthew Zuga, Director, has left the company  (posted on October 10 2025).
• Guido Neels has joined the company as Director  (posted on October 10 2025).

Click here to view some more movements at Elutia

Create your alert
to follow the executive moves at Elutia.

Elutia has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Elutia

• Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) | Elutia Inc.
• Elutia Reports First Quarter 2026 Results and Highlights NXT-41x Progress Toward $1.5 Billion U.S. Plastic and Reconstructive Surgery Market | Elutia Inc.
• Elutia to Present at the 16th Annual LD Micro Invitational on May 18th | Elutia Inc.
• Elutia to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026 | Elutia Inc.
• Elutia Reports Fourth Quarter and Full Year 2025 Financial Results; Initiates NXT-41 Regulatory Process | Elutia Inc.
• Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) | Elutia Inc.
• Elutia Regains Compliance with Nasdaq Listing Requirements | Elutia Inc.
• Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market | Elutia Inc.
• Elutia to Report Fourth Quarter 2025 Financial Results on Wednesday, March 11, 2026 | Elutia Inc.
• Where Purpose Meets Performance: Elutia Earns 2026 Great Place to Work Certification™ | Elutia Inc.
• View more press releases Close

Social media about Elutia

• Elutia on Wikipedia, Google News & Yahoo Finance
• Elutia on LinkedIn, X (Twitter) & YouTube